Profiles

Moshe Vardi, MD

Adjunct Assistant Professor, Biostatistics - Boston University School of Public Health

Biography

Dr. Vardi is a Global Clinical Development Lead at Shire, previously a Clinical Research Medical Advisor at Novartis, the Medical Director at the Harvard Clinical Research Institute (HCRI), and an Assistant Professor (adj) at the Boston University School of Public Health (BUSPH). Dr. Vardi has a wide range of clinical, scientific and clinical research experience in diverse therapeutic indications, with involvement on both scientific and operational aspects. His current main focus is in the rare disease space, and prior to that in the cardio-metabolic space, with a footprint in design, execution, summary of results and submission to health agencies. His career in the field also includes a position as an Acting Director of an Internal Medicine unit, and board member of several national and international societies and professional working groups, and 15 years of experience in the Medical Device and Pharma industry. Dr. Vardi is a recipient of the European Federation of Internal Medicine Honorary Fellow award (2011). His research has been published in leading, peer-reviewed scientific journals, and has served as an Associate Editor for the European Journal of Internal Medicine.

Education

  • Tel Aviv University (TAU), MD Field of Study: Medicine
  • Tel Aviv University (TAU), BSc Field of Study: Engineering

Publications

  • Published on 10/1/2023

    Treangen TJ, Vardi MY. The long game of tenure. Nat Biotechnol. 2023 Oct; 41(10):1373-1374. PMID: 37626231.

    Read At: PubMed
  • Published on 5/11/2021

    Farkas H, Reshef A, Caballero T, Ortega López MC, Kessel A, Vardi M, Hao J, Aberer W. Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema. Pediatr Allergy Immunol. 2021 08; 32(6):1392-1396. PMID: 33851451.

    Read At: PubMed
  • Published on 1/17/2020

    Girolami A, Rolland C, Sexton D, Vardi M, Bernstein JA. Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: A systematic literature review of case reports. Allergy Asthma Proc. 2020 01 17; 41(1):10-18. PMID: 31888778.

    Read At: PubMed
  • Published on 1/1/2020

    Fukunaga A, Morita E, Miyagi T, Eto K, Shimizu A, Kagami S, Yamamoto H, Vardi M, Tang Y, Wang Y, Hide M. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY]. Arerugi. 2020; 69(3):192-203. PMID: 32435020.

    Read At: PubMed
  • Published on 10/28/2019

    Hide M, Fukunaga A, Maehara J, Eto K, Hao J, Vardi M, Nomoto Y. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study. Allergol Int. 2020 Apr; 69(2):268-273. PMID: 31672405.

    Read At: PubMed
  • Published on 9/17/2019

    Girolami A, Rolland C, Sexton D, Vardi M, Bernstein JA. Long-term safety outcomes of prekillikrein (Fletcher factor) deficiency: A systematic literature review of case reports. Allergy Asthma Proc. 2019 Sep 17. PMID: 31530337.

    Read At: PubMed
  • Published on 5/29/2019

    Aygören-Pürsün E, Soteres DF, Nieto-Martinez SA, Christensen J, Jacobson KW, Moldovan D, Van Leerberghe A, Tang Y, Lu P, Vardi M, Schranz J, Martinez-Saguer I. A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema. Pediatr Allergy Immunol. 2019 08; 30(5):553-561. PMID: 30968444.

    Read At: PubMed
  • Published on 1/23/2019

    Lumry WR, Martinez-Saguer I, Yang WH, Bernstein JA, Jacobs J, Moldovan D, Riedl MA, Johnston DT, Li HH, Tang Y, Schranz J, Lu P, Vardi M, Farkas H. Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1610-1618.e4. PMID: 30682573.

    Read At: PubMed
  • Published on 1/1/2018

    Hide M, Fukunaga A, Maehara J, Eto K, Hao J, Vardi M, Nomoto Y. [EFFICACY, PHARMACOKINETICS, AND SAFETY OF ICATIBANT FOR THE TREATMENT OF JAPANESE PATIENTS WITH AN ACUTE ATTACK OF HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY]. Arerugi. 2018; 67(2):139-147. PMID: 29553114.

    Read At: PubMed
  • Published on 10/13/2016

    Muady GF, Bitterman H, Laor A, Vardi M, Urin V, Ghanem-Zoubi N. Hemoglobin levels and blood transfusion in patients with sepsis in Internal Medicine Departments. BMC Infect Dis. 2016 10 13; 16(1):569. PMID: 27737630.

    Read At: PubMed